Related Experiment Video
Updated: Aug 6, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study
G Pavone1, E Lamanna1, M Pacilli1
1Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Frontiers in Surgery
|July 17, 2026
Summary
A study found that 14.4% of patients undergoing surgery for multinodular goiter (MNG) had incidental thyroid carcinoma. Papillary thyroid carcinoma was most common, and younger patients were more likely to have malignancy.
Area of Science:
- Endocrinology
- Surgical Oncology
- Pathology
Background:
- Multinodular goiter (MNG) is a common thyroid condition.
- Malignancy can be incidentally found during surgery for MNG, with varying reported prevalence.
- This study investigates the incidence and characteristics of incidental thyroid carcinoma in MNG patients undergoing surgery.
Purpose of the Study:
- To determine the incidence of incidental thyroid carcinoma in patients operated on for MNG.
- To analyze demographic and clinicopathological features associated with incidental thyroid carcinoma.
- To evaluate the relationship between patient characteristics and the occurrence of malignancy.
Main Methods:
- Retrospective study of 223 patients with MNG undergoing thyroidectomy (January 2018 - May 2024).
- Data collected included clinical, demographic, and pathological information.
- Statistical analyses were performed to identify associations with incidental carcinoma.
Main Results:
- Incidental thyroid carcinoma was found in 14.4% of patients (32 out of 223).
- Papillary thyroid carcinoma was the most frequent subtype (78.1%).
- Patients with carcinoma were significantly younger (mean age 49.4 vs. 56.2 years; p=0.008), and increasing age was linked to reduced malignancy risk (OR=0.963; p=0.009).
Conclusions:
- Incidental thyroid carcinoma is a frequent finding in MNG surgery patients.
- Papillary carcinoma is the predominant subtype; no significant sex differences were noted.
- Current data are insufficient to alter thyroid nodule screening strategies despite age and thyroid weight considerations.

